HANGZHOU, Aug 21, 2021 – (ACN Newswire via SEAPRWire.com) – New Horizon Health (6606.HK) (the “Company”), the first public listed cancer screening company in China, has today announced its financial report for the first half year ended 30 June 2021. In the first half of 2021, the Company’s total revenue was RMB43.9 million, a year-on-year... » read more
SINGAPORE – In a year, Singapore will add 33 high-cost cancer drugs to the Medication Assistance Fund (MAF), which subsidises expensive drugs that have been deemed clinically necessary. This means people who have trouble paying for such drugs could get them at up to 75 per cent off, depending on their per capita household income. There... » read more
HONG KONG, Jul 6, 2021 – (ACN Newswire via SEAPRWire.com) – ACT Genomics Co. Ltd. (“ACT Genomics” or “the Group”) has completed the acquisition of MC Diagnostics Ltd. (“MCD”), a specialist molecular diagnostic company based in the United Kingdom, which marks the Group’s entry into the European precision medicine market. MCD machine in operation Founded... » read more
TOKYO, May 14, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and the National Cancer Center Japan announced today that both parties have entered into a joint research and development (R&D) agreement concerning “Basic research on the drug discovery and development to accelerate development of anticancer drugs in treatment of patients with rare... » read more
TOKYO, Apr 23, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and MSD K.K., a subsidiary of Merck & Co., Inc., Kenilworth, N.J., U.S.A., (known as MSD outside the United States and Canada) announced today an application submission in Japan for the additional indication of Eisai’s in-house discovered and developed multiple receptor tyrosine... » read more
What are some symptoms of gynaecologic cancers that women should not ignore? Most gynaecological cancers present with abnormal vaginal bleeding such as intermenstrual bleeding, bleeding after sex, or postmenopausal bleeding. Keep a lookout for vaginal discharge that may range from pink, watery and bloody to thick, brown and foul-smelling. Additionally, symptoms can include pain in... » read more
SINGAPORE – National University of Singapore (NUS) researchers can now identify cancer cells by studying their acidity or pH levels using artificial intelligence technology. This technique could be potentially useful in detecting cancer cells in tissue samples, either obtained from tumour biopsies or liquid biopsies, which are blood tests. “As the number of cells in... » read more
SINGAPORE – A targeted method of administering chemotherapy drugs to patients with colon, gastric and ovarian cancers could potentially bring hope to those who are in the late stages of their ailment. The Pressurised Intraperitoneal Aerosol Chemotherapy (Pipac) method distributes drugs in aerosol form – through a device called a port – directly into the... » read more
TOKYO, Mar 12, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that it has received orphan drug designation for LENVIMA (generic name: lenvatinib mesylate), the orally available multiple receptor kinase inhibitor discovered by Eisai, with a prospective indication for uterine body cancer, by the Ministry of Health, Labour and Welfare (MHLW).... » read more
TOKYO, Mar 8, 2021 – (JCN Newswire via SEAPRWire.com) – NEC Corporation (TSE: 6701) today announced that it has joined a landmark public-private initiative, the Norwegian Precision Cancer Medicine Implementation Consortium (CONNECT), a collaboration between 22 key public and private partners for promoting precision cancer medicine. CONNECT is one of four interconnected initiatives in Norway... » read more
TOKYO, Feb 22, 2021 – (JCN Newswire) – Eisai Co., Ltd. announced today that it has received orphan drug designation for a prospective indication for unresectable biliary tract cancer with FGFR2 gene fusion by the Ministry of Health, Labour and Welfare, Japan (MHLW) for its in-house discovered fibroblast growth factor (FGF) receptor (FGFR1, FGFR2, FGFR3)... » read more
TOKYO, Feb 4, 2021 – (ACN Newswire) – Olympus Corporation (Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) announced today that it has been selected(1) by Japan’s Ministry of Health, Labour and Welfare (MHLW) to implement the Japan-Russia Medical Cooperation Promotion Project in the field of endoscopy for the fiscal year ending March, 2021.... » read more
HONG KONG, Jan 28, 2021 – (ACN Newswire) – Broncus Holding Corporation (“Broncus”), a global leader in diagnostic and therapeutic technology for lung diseases, announced today the closing of a Series D round of funding led by FountainVest Partners. Other investors include Exome Asset Management, Summer Capital, and Valliance Capital. Broncus is dedicated to the... » read more
SINGAPORE – A year after she was informed she had a rare breast cancer, accounts clerk Stella Seah was told she may have been wrongly diagnosed with a more aggressive form of the disease. By then, the 46-year-old had received 17 rounds of trastuzumab, a drug which can cause diarrhoea, chills and fever. In about... » read more
TOKYO, Jan 12, 2021 – (JCN Newswire) – Eisai Co., Ltd. has announced that presentations on a series of abstracts highlighting updates on its in-house discovered lenvatinib mesylate (product name: LENVIMA, the orally available kinase inhibitor, “lenvatinib”) will be given at the Gastrointestinal Cancers Symposium Virtual Meeting, from January 15 to 17, 2021. At this... » read more
Breast cancer is a disease that involves abnormal cell growth in the breast, which can spread to other parts of the body and cause health problems. It is the most common type of cancer in women internationally. In Singapore, breast cancer accounts for almost 30 per cent of cancers in women. Breast cancers can have... » read more
The hospital is no conventional location for wedding shoots, but it is a place that bears great significance for Ms Artika Raemi, 26, and Mr Aziz Abdullah, 28. The chemotherapy bay at the National University Cancer Institute, Singapore, was where Mr Aziz supported his fiancee through her breast cancer journey. Ms Artika, who is a... » read more
The new blood test for early detection of gastric cancer takes around three hours to process in a clinical lab and patients can expect results to be delivered to their doctor in a week. The blood test detects the patterns of microRNA – a type of genetic material present in the blood sample. Most cancers,... » read more
SINGAPORE – A blood test that can detect gastric cancer in its early stages has been developed and is currently being evaluated for use in hospitals and clinics, said the National University Health System (NUHS) on Friday (Oct 23). In Singapore, gastric cancer is the fifth cause of cancer deaths in men and the sixth... » read more